Pharma

The Readout Elaine Chen

STAT Plus: Bernie Sanders keeps the heat on Novo’s high prices

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about pharma patent maneuvers, the U.S. warning J&J, and more

Exclusive Ed Silverman and Michael Nolan

STAT Plus: Inside the quiet strategy pharma giants are using to fend off generics and drive up the cost of medicines

Pharmalot Ed Silverman

STAT Plus: U.S. agency threatens J&J with sanctions if it switches payments to 340B hospitals

The Readout Elaine Chen

STAT Plus: FDA formalizes protocol for international cancer trials

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about an Express Scripts lawsuit against FTC, AMR deaths, and more

Pharmalot Ed Silverman

STAT Plus: Express Scripts sues FTC over a ‘biased’ report about pharmacy benefit managers

Health tech Mario Aguilar

STAT Plus: What pharma companies and insurers think about Medicare’s plan to cover digital treatments

Who to Know Meghana Keshavan

STAT Plus: 12 people shaping psychedelics drug development

Pharma Andrew Joseph

STAT Plus: The news from ESMO: An immunotherapy milestone, studying young-onset cancers, and more

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about an AstraZeneca bladder cancer drug, Genentech anxiety, and more

The Readout Meghana Keshavan

STAT Plus: The essential biotech updates of the day

Exclusive Kate Raphael

Pediatricians’ obesity guidelines rest on shaky evidence about eating disorder risks

Pharma Andrew Joseph

STAT Plus: Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study

Pharma Andrew Joseph

STAT Plus: The news from ESMO: The latest on anti-TIGIT data, a PD-(L)1 injection, and more

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharma Jonathan Wosen

STAT Plus: FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more

The Readout Elaine Chen

STAT Plus: Can GLP-1 drugs help with type 1 diabetes?

The Readout Elaine Chen

STAT Plus: Moderna cuts spending, and Sarepta’s ‘curse’ on Califf

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more

Pharmalot Ed Silverman

STAT Plus: FDA scolds AbbVie over ‘misleading’ TV ad for a migraine pill featuring Serena Williams

Biotech Brittany Trang

STAT Plus: ‘Sarepta’s like a curse on me’: FDA commissioner dismisses controversy over Elevidys

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Novo weight loss study, a GSK vaccine failure, and more

The Readout Meghana Keshavan

STAT Plus: Eli Lilly releases new data on weekly insulin

The Readout Meghana Keshavan

STAT Plus: Five biotech news stories you need to read today

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Roivant deal, limited access to medicines and more

Pharmalot Ed Silverman

STAT Plus: Pharma is still struggling to widen access to medicines — and reach patients — in low- and middle-income countries

Video Anna Yeo

STAT Plus: The little-known bill that made drugs more affordable